Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lijishuang lozenge
- Development stage
- Unknown
- Lead developer
- Jiangxi Bencao Tiangong Technology
- Administration
- Buccal
01
Overview
**Lijishuang lozenge** is an investigational oral lozenge developed by Jiangxi Bencao Tiangong for symptomatic treatment of acute pharyngitis associated with the traditional Chinese medicine exogenous wind-heat pattern. It was evaluated in China in a randomized, double-blind, placebo-controlled phase IIa study comparing high- and low-dose regimens over 5 days, with throat-pain resolution and safety as key outcomes. Its specific active composition, molecular targets, and pharmacologic mechanism have not been publicly established in the available trial information.
- Other names
- Lijishuang lozenge
Beyond the preview
Go deeper on Lijishuang lozenge.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lijishuang lozenge.